nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2D6—Hydroxyurea—head and neck cancer	0.297	0.36	CbGbCtD
Carbinoxamine—CYP2C8—Fluorouracil—head and neck cancer	0.178	0.215	CbGbCtD
Carbinoxamine—CYP2C9—Fluorouracil—head and neck cancer	0.124	0.15	CbGbCtD
Carbinoxamine—CYP2D6—Vinblastine—head and neck cancer	0.105	0.127	CbGbCtD
Carbinoxamine—CYP3A4—Vinblastine—head and neck cancer	0.0669	0.0809	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—head and neck cancer	0.0551	0.0667	CbGbCtD
Carbinoxamine—Neuritis—Vinblastine—head and neck cancer	0.0068	0.0552	CcSEcCtD
Carbinoxamine—Chest tightness—Docetaxel—head and neck cancer	0.00513	0.0417	CcSEcCtD
Carbinoxamine—Neuritis—Docetaxel—head and neck cancer	0.00322	0.0262	CcSEcCtD
Carbinoxamine—Euphoric mood—Fluorouracil—head and neck cancer	0.00286	0.0233	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00278	0.0226	CcSEcCtD
Carbinoxamine—Photosensitivity—Fluorouracil—head and neck cancer	0.00276	0.0224	CcSEcCtD
Carbinoxamine—Chest discomfort—Docetaxel—head and neck cancer	0.00272	0.0221	CcSEcCtD
Carbinoxamine—Agranulocytosis—Vinblastine—head and neck cancer	0.00265	0.0215	CcSEcCtD
Carbinoxamine—Drowsiness—Hydroxyurea—head and neck cancer	0.00259	0.021	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00254	0.0206	CcSEcCtD
Carbinoxamine—Irritability—Fluorouracil—head and neck cancer	0.00231	0.0188	CcSEcCtD
Carbinoxamine—Chills—Hydroxyurea—head and neck cancer	0.00209	0.0169	CcSEcCtD
Carbinoxamine—Vertigo—Vinblastine—head and neck cancer	0.00199	0.0162	CcSEcCtD
Carbinoxamine—Convulsion—Vinblastine—head and neck cancer	0.00192	0.0156	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00191	0.0155	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00183	0.0148	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00177	0.0144	CcSEcCtD
Carbinoxamine—Convulsion—Hydroxyurea—head and neck cancer	0.00175	0.0142	CcSEcCtD
Carbinoxamine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00174	0.0141	CcSEcCtD
Carbinoxamine—Anorexia—Vinblastine—head and neck cancer	0.00173	0.014	CcSEcCtD
Carbinoxamine—Paraesthesia—Vinblastine—head and neck cancer	0.00163	0.0132	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00162	0.0131	CcSEcCtD
Carbinoxamine—Anorexia—Hydroxyurea—head and neck cancer	0.00157	0.0128	CcSEcCtD
Carbinoxamine—Decreased appetite—Vinblastine—head and neck cancer	0.00157	0.0128	CcSEcCtD
Carbinoxamine—Constipation—Vinblastine—head and neck cancer	0.00155	0.0126	CcSEcCtD
Carbinoxamine—Feeling abnormal—Vinblastine—head and neck cancer	0.00149	0.0121	CcSEcCtD
Carbinoxamine—Somnolence—Hydroxyurea—head and neck cancer	0.00147	0.0119	CcSEcCtD
Carbinoxamine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00145	0.0118	CcSEcCtD
Carbinoxamine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00144	0.0117	CcSEcCtD
Carbinoxamine—Fatigue—Hydroxyurea—head and neck cancer	0.00142	0.0116	CcSEcCtD
Carbinoxamine—Constipation—Hydroxyurea—head and neck cancer	0.00141	0.0115	CcSEcCtD
Carbinoxamine—Vision blurred—Fluorouracil—head and neck cancer	0.00137	0.0112	CcSEcCtD
Carbinoxamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00136	0.0111	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00132	0.0107	CcSEcCtD
Carbinoxamine—Asthenia—Vinblastine—head and neck cancer	0.0013	0.0106	CcSEcCtD
Carbinoxamine—Convulsion—Fluorouracil—head and neck cancer	0.00126	0.0103	CcSEcCtD
Carbinoxamine—Agranulocytosis—Docetaxel—head and neck cancer	0.00126	0.0102	CcSEcCtD
Carbinoxamine—Diarrhoea—Vinblastine—head and neck cancer	0.00124	0.0101	CcSEcCtD
Carbinoxamine—Confusional state—Fluorouracil—head and neck cancer	0.0012	0.00974	CcSEcCtD
Carbinoxamine—Dizziness—Vinblastine—head and neck cancer	0.0012	0.00973	CcSEcCtD
Carbinoxamine—Asthenia—Hydroxyurea—head and neck cancer	0.00119	0.00963	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00116	0.00946	CcSEcCtD
Carbinoxamine—Tachycardia—Fluorouracil—head and neck cancer	0.00116	0.00943	CcSEcCtD
Carbinoxamine—Vomiting—Vinblastine—head and neck cancer	0.00115	0.00936	CcSEcCtD
Carbinoxamine—Headache—Vinblastine—head and neck cancer	0.00113	0.00922	CcSEcCtD
Carbinoxamine—Anorexia—Fluorouracil—head and neck cancer	0.00113	0.00921	CcSEcCtD
Carbinoxamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00113	0.00918	CcSEcCtD
Carbinoxamine—Hypotension—Fluorouracil—head and neck cancer	0.00111	0.00903	CcSEcCtD
Carbinoxamine—Dizziness—Hydroxyurea—head and neck cancer	0.00109	0.00887	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—head and neck cancer	0.00108	0.0088	CcSEcCtD
Carbinoxamine—Nausea—Vinblastine—head and neck cancer	0.00108	0.00874	CcSEcCtD
Carbinoxamine—Insomnia—Fluorouracil—head and neck cancer	0.00108	0.00874	CcSEcCtD
Carbinoxamine—Paraesthesia—Fluorouracil—head and neck cancer	0.00107	0.00867	CcSEcCtD
Carbinoxamine—Somnolence—Fluorouracil—head and neck cancer	0.00106	0.00859	CcSEcCtD
Carbinoxamine—Vomiting—Hydroxyurea—head and neck cancer	0.00105	0.00853	CcSEcCtD
Carbinoxamine—Dyspepsia—Fluorouracil—head and neck cancer	0.00105	0.0085	CcSEcCtD
Carbinoxamine—Headache—Hydroxyurea—head and neck cancer	0.00103	0.00841	CcSEcCtD
Carbinoxamine—Decreased appetite—Fluorouracil—head and neck cancer	0.00103	0.0084	CcSEcCtD
Carbinoxamine—Nausea—Hydroxyurea—head and neck cancer	0.000981	0.00797	CcSEcCtD
Carbinoxamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00098	0.00796	CcSEcCtD
Carbinoxamine—Urticaria—Fluorouracil—head and neck cancer	0.000945	0.00767	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—head and neck cancer	0.000929	0.00755	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—head and neck cancer	0.000911	0.0074	CcSEcCtD
Carbinoxamine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.000879	0.0173	CbGpPWpGaD
Carbinoxamine—Confusional state—Docetaxel—head and neck cancer	0.000865	0.00703	CcSEcCtD
Carbinoxamine—CYP2B6—Xenobiotics—CYP1A1—head and neck cancer	0.000848	0.0167	CbGpPWpGaD
Carbinoxamine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00084	0.00683	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—head and neck cancer	0.000838	0.0068	CcSEcCtD
Carbinoxamine—CYP2E1—Xenobiotics—CYP1A1—head and neck cancer	0.00083	0.0163	CbGpPWpGaD
Carbinoxamine—Anorexia—Docetaxel—head and neck cancer	0.000818	0.00665	CcSEcCtD
Carbinoxamine—Diarrhoea—Fluorouracil—head and neck cancer	0.000814	0.00661	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—head and neck cancer	0.000802	0.00651	CcSEcCtD
Carbinoxamine—CYP2E1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000798	0.0157	CbGpPWpGaD
Carbinoxamine—Dizziness—Fluorouracil—head and neck cancer	0.000786	0.00639	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—head and neck cancer	0.000776	0.00631	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—head and neck cancer	0.000771	0.00626	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—head and neck cancer	0.000763	0.0062	CcSEcCtD
Carbinoxamine—Vomiting—Fluorouracil—head and neck cancer	0.000756	0.00614	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—head and neck cancer	0.000756	0.00614	CcSEcCtD
Carbinoxamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000746	0.0147	CbGpPWpGaD
Carbinoxamine—Decreased appetite—Docetaxel—head and neck cancer	0.000746	0.00606	CcSEcCtD
Carbinoxamine—Headache—Fluorouracil—head and neck cancer	0.000745	0.00605	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—head and neck cancer	0.00074	0.00601	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—head and neck cancer	0.000734	0.00596	CcSEcCtD
Carbinoxamine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00073	0.0144	CbGpPWpGaD
Carbinoxamine—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000718	0.0141	CbGpPWpGaD
Carbinoxamine—Feeling abnormal—Docetaxel—head and neck cancer	0.000707	0.00575	CcSEcCtD
Carbinoxamine—Nausea—Fluorouracil—head and neck cancer	0.000706	0.00574	CcSEcCtD
Carbinoxamine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000704	0.0139	CbGpPWpGaD
Carbinoxamine—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00069	0.0136	CbGpPWpGaD
Carbinoxamine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.00064	0.0126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000616	0.0121	CbGpPWpGaD
Carbinoxamine—Asthenia—Docetaxel—head and neck cancer	0.000616	0.005	CcSEcCtD
Carbinoxamine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000589	0.0116	CbGpPWpGaD
Carbinoxamine—Diarrhoea—Docetaxel—head and neck cancer	0.000587	0.00477	CcSEcCtD
Carbinoxamine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000584	0.0115	CbGpPWpGaD
Carbinoxamine—Dizziness—Docetaxel—head and neck cancer	0.000568	0.00461	CcSEcCtD
Carbinoxamine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000567	0.0111	CbGpPWpGaD
Carbinoxamine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000562	0.011	CbGpPWpGaD
Carbinoxamine—Vomiting—Docetaxel—head and neck cancer	0.000546	0.00443	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—head and neck cancer	0.000538	0.00437	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—head and neck cancer	0.00051	0.00414	CcSEcCtD
Carbinoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000492	0.00968	CbGpPWpGaD
Carbinoxamine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000476	0.00936	CbGpPWpGaD
Carbinoxamine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00046	0.00906	CbGpPWpGaD
Carbinoxamine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000442	0.0087	CbGpPWpGaD
Carbinoxamine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000438	0.00861	CbGpPWpGaD
Carbinoxamine—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000426	0.00839	CbGpPWpGaD
Carbinoxamine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000419	0.00824	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—KISS1—head and neck cancer	0.000417	0.0082	CbGpPWpGaD
Carbinoxamine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000385	0.00758	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000373	0.00733	CbGpPWpGaD
Carbinoxamine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00037	0.00729	CbGpPWpGaD
Carbinoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000352	0.00692	CbGpPWpGaD
Carbinoxamine—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000348	0.00685	CbGpPWpGaD
Carbinoxamine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000347	0.00683	CbGpPWpGaD
Carbinoxamine—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000345	0.00678	CbGpPWpGaD
Carbinoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000345	0.00678	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—GRP—head and neck cancer	0.000343	0.00675	CbGpPWpGaD
Carbinoxamine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00034	0.00669	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000324	0.00637	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000319	0.00628	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000317	0.00624	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000313	0.00615	CbGpPWpGaD
Carbinoxamine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000311	0.00612	CbGpPWpGaD
Carbinoxamine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000308	0.00605	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000307	0.00604	CbGpPWpGaD
Carbinoxamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000298	0.00586	CbGpPWpGaD
Carbinoxamine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000294	0.00579	CbGpPWpGaD
Carbinoxamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000285	0.00561	CbGpPWpGaD
Carbinoxamine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000283	0.00558	CbGpPWpGaD
Carbinoxamine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000281	0.00552	CbGpPWpGaD
Carbinoxamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000279	0.0055	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000276	0.00543	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000274	0.00539	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.00027	0.00532	CbGpPWpGaD
Carbinoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000266	0.00523	CbGpPWpGaD
Carbinoxamine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000262	0.00516	CbGpPWpGaD
Carbinoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000245	0.00481	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000245	0.00481	CbGpPWpGaD
Carbinoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000242	0.00477	CbGpPWpGaD
Carbinoxamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000242	0.00475	CbGpPWpGaD
Carbinoxamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000241	0.00475	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000241	0.00475	CbGpPWpGaD
Carbinoxamine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000239	0.00471	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000227	0.00447	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000225	0.00443	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000223	0.00439	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000222	0.00437	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.00022	0.00433	CbGpPWpGaD
Carbinoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000216	0.00424	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—KISS1—head and neck cancer	0.00021	0.00413	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—STAT3—head and neck cancer	0.000208	0.00409	CbGpPWpGaD
Carbinoxamine—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000205	0.00403	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—MAPK3—head and neck cancer	0.000198	0.00391	CbGpPWpGaD
Carbinoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000198	0.0039	CbGpPWpGaD
Carbinoxamine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000198	0.00389	CbGpPWpGaD
Carbinoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000197	0.00387	CbGpPWpGaD
Carbinoxamine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00019	0.00373	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—MAPK1—head and neck cancer	0.000189	0.00372	CbGpPWpGaD
Carbinoxamine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000183	0.0036	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—GRP—head and neck cancer	0.000173	0.0034	CbGpPWpGaD
Carbinoxamine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000167	0.00328	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—PIK3CA—head and neck cancer	0.000164	0.00322	CbGpPWpGaD
Carbinoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00016	0.00315	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.00016	0.00315	CbGpPWpGaD
Carbinoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000158	0.00311	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000158	0.0031	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000157	0.00308	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000154	0.00304	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000152	0.00298	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000149	0.00294	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000148	0.00292	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000147	0.00289	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000146	0.00288	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000145	0.00285	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000135	0.00266	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—AKT1—head and neck cancer	0.000134	0.00263	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000133	0.00263	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—UROD—head and neck cancer	0.000133	0.00262	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—UROD—head and neck cancer	0.000131	0.00257	CbGpPWpGaD
Carbinoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00013	0.00255	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000128	0.00252	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000127	0.00249	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000121	0.00238	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000119	0.00234	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—KISS1—head and neck cancer	0.000119	0.00234	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000115	0.00225	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000113	0.00222	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—UROD—head and neck cancer	0.000113	0.00222	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000111	0.00219	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.00011	0.00217	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.00011	0.00216	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000109	0.00214	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KISS1—head and neck cancer	0.000108	0.00212	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000105	0.00207	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000104	0.00205	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000104	0.00204	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000103	0.00203	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—UROD—head and neck cancer	0.000101	0.00198	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—GRP—head and neck cancer	9.78e-05	0.00192	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—UROD—head and neck cancer	9.27e-05	0.00182	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—UROD—head and neck cancer	9.19e-05	0.00181	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—GRP—head and neck cancer	8.88e-05	0.00175	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.76e-05	0.00172	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.82e-05	0.00154	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.26e-05	0.00143	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.16e-05	0.00141	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.13e-05	0.0014	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.89e-05	0.00135	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.79e-05	0.00134	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	6.57e-05	0.00129	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KISS1—head and neck cancer	6.37e-05	0.00125	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	6.25e-05	0.00123	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	6.25e-05	0.00123	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—PIK3CA—head and neck cancer	6.07e-05	0.00119	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—UROD—head and neck cancer	6.06e-05	0.00119	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NAT2—head and neck cancer	5.54e-05	0.00109	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	5.43e-05	0.00107	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NAT2—head and neck cancer	5.42e-05	0.00107	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GRP—head and neck cancer	5.24e-05	0.00103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT6—head and neck cancer	5.09e-05	0.001	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	5.02e-05	0.000988	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.98e-05	0.000979	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.93e-05	0.000969	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—DPYD—head and neck cancer	4.85e-05	0.000955	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—DPYD—head and neck cancer	4.75e-05	0.000935	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NAT2—head and neck cancer	4.69e-05	0.000922	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—YAP1—head and neck cancer	4.61e-05	0.000906	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—YAP1—head and neck cancer	4.51e-05	0.000888	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—YAP1—head and neck cancer	4.51e-05	0.000886	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.44e-05	0.000874	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.4e-05	0.000865	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NAT2—head and neck cancer	4.18e-05	0.000823	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—DPYD—head and neck cancer	4.11e-05	0.000809	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.05e-05	0.000797	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.01e-05	0.000789	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—YAP1—head and neck cancer	3.9e-05	0.000767	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NAT2—head and neck cancer	3.85e-05	0.000757	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NAT2—head and neck cancer	3.81e-05	0.00075	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—DPYD—head and neck cancer	3.67e-05	0.000722	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—YAP1—head and neck cancer	3.48e-05	0.000685	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—DPYD—head and neck cancer	3.37e-05	0.000664	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—DPYD—head and neck cancer	3.34e-05	0.000658	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—YAP1—head and neck cancer	3.2e-05	0.00063	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—YAP1—head and neck cancer	3.17e-05	0.000624	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.93e-05	0.000576	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—TYMS—head and neck cancer	2.77e-05	0.000544	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.73e-05	0.000538	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—TYMS—head and neck cancer	2.71e-05	0.000533	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—head and neck cancer	2.68e-05	0.000527	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—head and neck cancer	2.62e-05	0.000515	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.62e-05	0.000515	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—IL2—head and neck cancer	2.61e-05	0.000513	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.59e-05	0.00051	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—head and neck cancer	2.56e-05	0.000505	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.56e-05	0.000503	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	2.54e-05	0.000499	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NAT2—head and neck cancer	2.52e-05	0.000495	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.38e-05	0.000469	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—head and neck cancer	2.37e-05	0.000465	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TYMS—head and neck cancer	2.34e-05	0.000461	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.31e-05	0.000455	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.28e-05	0.000449	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—head and neck cancer	2.22e-05	0.000436	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DPYD—head and neck cancer	2.21e-05	0.000434	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.19e-05	0.000432	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—YAP1—head and neck cancer	2.09e-05	0.000412	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.09e-05	0.000411	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.08e-05	0.000409	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000406	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	2.03e-05	0.0004	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.98e-05	0.000389	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.96e-05	0.000385	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.92e-05	0.000378	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.91e-05	0.000375	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	1.9e-05	0.000374	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.9e-05	0.000374	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.88e-05	0.000371	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.82e-05	0.000358	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	1.81e-05	0.000356	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	1.81e-05	0.000356	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.8e-05	0.000355	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.8e-05	0.000355	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.8e-05	0.000354	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.79e-05	0.000351	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.73e-05	0.00034	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.61e-05	0.000317	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.57e-05	0.000309	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.54e-05	0.000303	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.51e-05	0.000297	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.47e-05	0.000289	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.45e-05	0.000286	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.41e-05	0.000278	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000275	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.36e-05	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTEN—head and neck cancer	1.34e-05	0.000264	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTEN—head and neck cancer	1.32e-05	0.000259	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.31e-05	0.000259	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.3e-05	0.000257	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.28e-05	0.000252	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.26e-05	0.000247	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.24e-05	0.000244	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.19e-05	0.000234	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.000234	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.18e-05	0.000232	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.16e-05	0.000229	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000224	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.12e-05	0.000221	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.000211	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.00021	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.06e-05	0.000209	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.02e-05	0.0002	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	9.48e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTEN—head and neck cancer	9.34e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	9.29e-06	0.000183	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	9.28e-06	0.000183	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTEN—head and neck cancer	9.26e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—head and neck cancer	8.97e-06	0.000177	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HRAS—head and neck cancer	8.58e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	8.03e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—head and neck cancer	7.75e-06	0.000152	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—head and neck cancer	7.59e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—head and neck cancer	7.58e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.17e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—head and neck cancer	7e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.59e-06	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—head and neck cancer	6.56e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.53e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTEN—head and neck cancer	6.11e-06	0.00012	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—head and neck cancer	5.85e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—head and neck cancer	5.38e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—head and neck cancer	5.34e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.31e-06	8.48e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.52e-06	6.93e-05	CbGpPWpGaD
